Centocor ReoPro plus low-dose heparin reduces angioplasty complications 70% -- EPILOG final data.
Executive Summary
CENTOCOR REOPRO PLUS LOW-DOSE HEPARIN REDUCES ANGIOPLASTY COMPLICATIONS by 70%, investigators reported at the annual European Society of Cardiology meeting in Birmingham, England the week of Aug. 23. The Evaluation in PTCA to Improve Long-term Outcome with ReoPro GP IIb/IIIa blockage, or EPILOG, study randomized ReoPro patients to low-dose or high-dose heparin.